Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.
Pizzorno G, Yee L, Burtness BA, Marsh JC, Darnowski JW, Chu MY, Chu SH, Chu E, Leffert JJ, Handschumacher RE, Calabresi P.
Clin Cancer Res. 1998 May;4(5):1165-75.PMID: 9607574 [PubMed - indexed for MEDLINE]Related articlesFree article